(Updates shares, adds trial details and background in paragraphs 2, 3) Sept 29 (Reuters) – UniQure said its gene therapy for Huntington's disease fell short of statistical significance on the main
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Deepa Seetharaman SAN FRANCISCO, Sept 29 (Reuters) - Current and former OpenAI and Google…
By Deepa Seetharaman SAN FRANCISCO, Sept 29 (Reuters) - Current and former OpenAI and Google…
EU ENERGY COMMISSIONER: BETTER TO HAVE LOWER TAXES ON ELECTRICITY THAN YOU HAVE ON GAS,…
VIDEO SHOWS: ARCHIVE FOOTAGE OF FIFA HEADQUARTERS, FIFA PRESIDENT INFANTINO, UEFA PRESIDENT ALEKSANDER CEFERIN, UEFA…
(Adds background, quote paragraphs 3-5) WASHINGTON, Sept 29 (Reuters) - Russian President Vladimir Putin's envoy…
By Deepa Seetharaman SAN FRANCISCO, Sept 29 (Reuters) - Current and former OpenAI and Google…